Andrzej Wawrzyk out of Deontay Wilder fight after failed drug test
Heavyweight contender Andrzej Wawrzyk, who was due to challenge WBC champion Deontay Wilder on February 25 at the Legacy Arena in Birmingham, Alabama, has failed a drug test.
Poland's Wawrzyk tested positive for an anabolic steroid during random drug testing, which was carried out by the Voluntary Anti-Doping Association, as part of the WBC’s Clean Boxing Program.
WBC president Mauricio Sulaiman tweeted: "WBC confirms that Andrzej Wawrzyk has tested positive anabolic steroid 'Stanozolol Metabolites'. The fight was contracted for out of competition surprise testing and this is how tragedies are prevented. There is no other way but Clean Boxing! Protect our boxers! Stand tall with VADA testing."
Now American Wilder needs a new opponent for his next title defence.
This is the second time in a row that Wilder's original opponent has failed a drug test. Wilder was scheduled to face mandatory challenger Alexander Povetkin in Moscow last May, but the Russian tested positive for the banned substance meldonium and the fight was called off.
Wilder instead faced Chris Arreola in July and stopped him in eight one-sided rounds.
WBO heavyweight champion Joseph Parker could be a possible replacement opponent. The two fighter's promoters are reportedly in negotiations for a unification clash.